Work

Anticancer Efficacy of HPPH-PDT Synergies with BCG-Immunotherapy or COX-2 Inhibitor in Treating Bladder Cancer

Year: 2026

Type: article

Source: Molecular Pharmaceutics

DOI: 10.1021/acs.molpharmaceut.5c01678

Authors: Farukh A. Durrani, Joseph Cacaccio, William Potter, Mykhaylo Dukh, Mehrgan Ghazaeian, Ahmed A. Hussein, Omar M. Ibrahim, Pawel Kalinski, Paras N. Prasad, Heinz Baumann, Khurshid A. Guru, Ravindra K. Pandey

Institutions: Roswell Park Comprehensive Cancer Center, University at Buffalo, State University of New York, Photolitec (United States)

Language: English

Topic: Photodynamic Therapy Research Studies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Roswell Park Cancer Institute, National Institutes of Health, National Cancer Institute

Awards: PDT Optimization and Mechanisms, G2367408380, Targeting the Chemokine System to Sensitize Tumors to Immunotherapy, G614789863, G6706297117, Fluorescence Image-Guided Near Infrared (NIR) Photodynamic Therapy (PDT) Agent

OpenAlex ID: W7147716461

FWCI:

Cites: 55

Cited by:

Related to: